A case of interstitial lung diseases in patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)

Japanese Journal of Cancer and Chemotherapy

Volumn 38, Issue 2, 2011, Pages 317-320

  Nakagawa, Masafumi ^a   Hamada, Aiko ^a   Yoshihara, Yukari ^a   Ishizaka, Toshihiko ^a   Fukushima, Makoto ^a   Takahashi, Naotsugu ^a   Sawada, Ryugo ^a   Mukai, Junji ^a  

^a Izumi Municipal Hospital   (Japan)

Author keywords

FOLFOX4 bevacizumab; Interstitial pneumonia

Indexed keywords

BEVACIZUMAB; CORTICOSTEROID; FLUOROURACIL; FOLINIC ACID; MEPREDNISONE; OXALIPLATIN;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSPNEA; HUMAN; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; RECTUM CANCER; RESPIRATORY FAILURE; THORAX RADIOGRAPHY; TREATMENT DURATION; WORLD HEALTH ORGANIZATION;

EID: 79957572748     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology v.3.2009. Colon/ Rectral Cancer.
2. de Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16): 2938-2947, 2000. (Pubitemid 30644117)
3. Giantonio BJ, Catalano PJ, Meropol NJ, et at Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25 (12): 1539-1544, 2007. (Pubitemid 46733080)
4. http://www.info.pmda.go.jp/
5. Unemi N and Takeda S: Studies on combination therapy with 1-(tetrahydro-2-furanyl)-5-fluorouracil plus uracil. Effects of uracil on in vitro metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil and 5-fluorouracil. Chemotherapy 29: 176-184, 1981.
6. Hooton JW and Hoffbrand AV: Thymidine kinase in megaloblastic anaemia. Br J Haematol 33(4): 527-537, 1976.
7. Garrido M, O'Brien A, González S, et al: Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report. Chest 132(6): 1997-1999, 2007.
8. Wilcox BE, Ryu JH and Kalra S: Exacerbation of pre-existing interstitial lung disease after oxaliplatin therapy: a report of three cases. Respir Med 102(2): 273-279, 2008. (Pubitemid 350296903)
9. Gagnadoux F, Roiron C, Carrie E, et al: Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer. Am J Clin Oncol 25(4): 388-390, 2002. (Pubitemid 34864035)
10. Yagüe XH, Soy E, Merino BQ, et al: Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer. Clin Transi Oncol 7(11): 515-517, 2005.
11. Pasetto LM and Monfardini S: Is acute dyspnea related to oxaliplatin administration? World J Gastroenterol 12(36): 5907-5908, 2006.
12. Muneoka K, Shirai Y, Sasaki M, et al: Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX). Int J Clin Oncol 14(5): 457-459, 2009.
13. Monnet I, Soulié P, de Cremoux H, et al: Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol 19(2): 458-463, 2001. (Pubitemid 32112859)